Literature DB >> 2791250

Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography.

J J Armbrecht1, D B Buxton, R C Brunken, M E Phelps, H R Schelbert.   

Abstract

Experimental studies of animals have previously demonstrated the validity of [1-11C]acetate as a tracer of oxidative metabolism for use with positron emission tomography. The present study was undertaken to define in normal human volunteers the relation between myocardial clearance kinetics of [1-11C]acetate, and the rate-pressure product as an index of myocardial oxygen consumption. Twenty-two studies were performed of 12 volunteers. The rate-pressure product was increased with continuous supine bicycle exercise in six studies. Of the 16 resting studies, seven were performed in the fasted state and nine following an oral glucose load, to define possible effects of substrate availability on the tracer-tissue kinetics. Myocardial tissue time-activity curves were biexponential. Clearance of activity was homogeneous throughout the myocardium. The rate constants k1, obtained from biexponential fitting, and kmono, obtained by monoexponential fitting of the initial linear portion of the time-activity curves, correlated well with the rate-pressure product. Although the correlation coefficient was higher for k1 than for kmono (0.95 vs. 0.91), analysis on a sectorial basis showed less regional variability in kmono. This suggests that kmono, which is more practical than k1 because it requires shorter acquisition times, may be more clinically and experimentally useful for detection of myocardial segments with abnormal oxygen consumption. Overall, changes in myocardial substrate supply were without significant effect on the relation between the rate constants (k1 and kmono) and the rate-pressure product, although a small decrease in kmono/rate-pressure product was observed following oral glucose by paired analysis in four subjects. It is concluded that [1-11C]acetate can be used for the noninvasive measurement of myocardial oxygen consumption in humans with positron emission tomography, and, thus, has clinical and experimental potential as a tool for the understanding and diagnosis of myocardial disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791250     DOI: 10.1161/01.cir.80.4.863

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

1.  Use of carbon 11-acetate for the measurement of myocardial oxygen consumption.

Authors:  O Akinboboye; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

3.  Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography.

Authors:  Masanao Naya; Satoru Chiba; Hiroyuki Iwano; Satoshi Yamada; Chietsugu Katoh; Osamu Manabe; Keiichiro Yoshinaga; Yoshiro Matsui; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

Review 4.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

5.  Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Bradley J Kemp; Barry A Borlaug; Brian P Mullan; Atta Behfar; Sorin V Pislaru; Marat Fudim; Margaret M Redfield; Panithaya Chareonthaitawee
Journal:  Circ Heart Fail       Date:  2019-10-15       Impact factor: 8.790

Review 6.  Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease.

Authors:  P G Camici
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

7.  Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.

Authors:  Marvin W Kronenberg; Gerald I Cohen; Marlo F Leonen; Thomas A Mladsi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

8.  Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Henry Ooi; Douglas B Sawyer; Mark A Lawson; Marvin W Kronenberg
Journal:  J Card Fail       Date:  2013-10-29       Impact factor: 5.712

9.  Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart.

Authors:  M E Jessen; T E Kovarik; F M Jeffrey; A D Sherry; C J Storey; R Y Chao; W S Ring; C R Malloy
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus.

Authors:  M Mäntysaari; J Kuikka; J Mustonen; K Tahvanainen; E Vanninen; E Länsimies; M Uusitupa
Journal:  Clin Auton Res       Date:  1996-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.